Jim Simons’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Jim Simons’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-126,480	Closed	-$1.14M	–	3704
2016 Q3	$1.14M	Buy	+126,480	New	+$899K	﹤0.01%	2509
2016 Q2	–	Sell	-572,946	Closed	-$2.64M	–	3749
2016 Q1	$2.64M	Buy	572,946 +40,066	+8%	+$161K	0.01%	2040
2015 Q4	$2.77M	Buy	532,880 +286,860	+117%	+$1.66M	0.01%	1901
2015 Q3	$1.49M	Buy	+246,020	New	+$3.01M	﹤0.01%	2163

Jim Simons's RPTP Position: Q4 2016 in Review

Jim Simons sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 126,480 shares — an estimated $1.14M sold.

Jim Simons first reported a position in RPTP in Q3 2015 and held it in 4 quarters. The position peaked at $2.77M in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Jim Simons reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Jim Simons sold 126,480 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.14M.
Jim Simons first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 4 quarters.
Jim Simons's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.77M in Q4 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.